Rise Advisors’s Clorox CLX Stock Holding History

Rise Advisors’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-97	Closed	-$12K	–	356
2025 Q3	$12K	Buy	97 +9	+10%	+$1.12K	﹤0.01%	894
2025 Q2	$10.6K	Buy	88 +4	+5%	+$534	﹤0.01%	960
2025 Q1	$12.3K	Sell	84 -4	-5%	-$611	0.01%	839
2024 Q4	$14.3K	Buy	88 +1	+1%	+$164	0.01%	851
2024 Q3	$14.2K	Hold	87	–	–	0.01%	892
2024 Q2	$11.8K	Buy	87 +1	+1%	+$139	0.01%	944
2024 Q1	$13.2K	Buy	+86	New	+$12.8K	0.01%	949

Other funds holding CLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Rise Advisors's CLX Position: Q4 2025 in Review

Rise Advisors sold out of Clorox (CLX) in Q4 2025, closing a stake of 97 shares — an estimated $12K sold.

Rise Advisors first reported a position in CLX in Q1 2024 and held it in 7 quarters. The position peaked at $14.3K in Q4 2024. 1,053 funds tracked by Wall St. Rank hold CLX as of Q4 2025.

Rise Advisors reported no remaining Clorox position as of Q4 2025 after selling out during the quarter.
Rise Advisors sold 97 Clorox shares in Q4 2025, an estimated $12K.
Rise Advisors first reported a position in Clorox in Q1 2024 and held it in 7 quarters.
Rise Advisors's Clorox position peaked at $14.3K in Q4 2024.
1,053 funds tracked by Wall St. Rank held Clorox as of Q4 2025.

Based on Rise Advisors's 13F filing for Q4 2025, filed 11 Feb 2026.